BMY Bristol Myers Squibb PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BMY
- PE Ratio
As of May 16, 2025, the Bristol Myers Squibb stock's P/E ratio is 17.44. This takes into account the latest EPS of $2.68 and stock price of $46.75.
BMY PE ratio history
The PE ratio of Bristol Myers Squibb has averaged 43.27 over the last ten years. The current price-to-earnings ratio of 17.44 is 60% less than the historical average. Analyzing the last ten years, BMY's PE ratio reached its highest point in the Jun 2018 quarter at 221.36, when the price was $55.34 and the EPS was $0.25. The lowest point was recorded in the Jun 2019 quarter, when it reached 11.93 with a price of $45.35 and an EPS of $3.8.
Bristol Myers Squibb PE ratio by year
Maximum annual increase: 358.93% in 2017
Maximum annual decrease: -82.81% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $56.56 | -$4.41 |
| 2023 | 13.22 | -45.44% | $51.31 | $3.88 |
| 2022 | 24.23 | 22.44% | $71.95 | $2.97 |
| 2021 | 19.79 | N/A | $62.35 | $3.15 |
| 2020 | N/A | N/A | $62.03 | -$3.99 |
| 2019 | 31.78 | 84.02% | $64.19 | $2.02 |
| 2018 | 17.27 | -82.81% | $51.98 | $3.01 |
| 2017 | 100.46 | 358.93% | $61.28 | $0.61 |
| 2016 | 21.89 | -70.09% | $58.44 | $2.67 |
| 2015 | 73.18 | 49.99% | $68.79 | $0.94 |
| 2014 | 48.79 | 43.21% | $59.03 | $1.21 |
| 2013 | 34.07 | 22.33% | $53.15 | $1.56 |
| 2012 | 27.85 | 72.23% | $32.59 | $1.17 |
| 2011 | 16.17 | 9.93% | $35.24 | $2.18 |
| 2010 | 14.71 | 211.65% | $26.48 | $1.8 |
Bristol Myers Squibb PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 22.76 | N/A | $60.99 | $2.68 |
| Dec 2024 | N/A | N/A | $56.56 | -$4.41 |
| Sep 2024 | N/A | N/A | $51.74 | -$3.59 |
| Jun 2024 | N/A | N/A | $41.53 | -$3.25 |
| Mar 2024 | N/A | N/A | $54.23 | -$3.09 |
| Dec 2023 | 13.22 | -9.58% | $51.31 | $3.88 |
| Sep 2023 | 14.62 | -13.59% | $58.04 | $3.97 |
| Jun 2023 | 16.92 | -15.53% | $63.95 | $3.78 |
| Mar 2023 | 20.03 | -17.33% | $69.31 | $3.46 |
| Dec 2022 | 24.23 | 5.3% | $71.95 | $2.97 |
| Sep 2022 | 23.01 | -9.16% | $71.09 | $3.09 |
| Jun 2022 | 25.33 | -1.48% | $77 | $3.04 |
| Mar 2022 | 25.71 | 29.91% | $73.03 | $2.84 |
| Dec 2021 | 19.79 | N/A | $62.35 | $3.15 |
| Sep 2021 | N/A | N/A | $59.17 | -$2.37 |
BMY Price vs fair value
BMY average PE ratio chart
The current PE ratio of BMY is under its 3, 5 and 10-year averages.
BMY PE vs peers
BMY's PE ratio is less than its peer stocks LLY and ABBV, but it is above JNJ's and NVS's. Bristol Myers Squibb's current PE ratio of 17.44 is less than the average of its peers, which is 30.01.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.04 | $190.99B |
| PFE Pfizer Inc | 16.42 | $129.8B |
| JNJ Johnson & Johnson | 16.7 | $364.11B |
| NVS Novartis AG | 17.02 | $214.72B |
| BMY Bristol Myers Squibb Co | 17.44 | $95.14B |
| ABT Abbott Laboratories | 17.46 | $234.53B |
| AMGN Amgen Inc | 24.65 | $146.48B |
| AZN Astrazeneca plc | 27.41 | $213.31B |
| LLY ELI LILLY & Co | 61.38 | $717.81B |
| ABBV AbbVie Inc | 77.97 | $325.05B |
Frequently asked questions
What is Bristol Myers Squibb's PE ratio?
As of May 16, 2025, BMY stock has a price to earnings ratio of 17.44.
What is the 3-year average PE ratio for Bristol Myers Squibb (BMY)?
The 3-year average PE ratio for BMY stock is 20.02.
What is the 5-year average PE ratio for Bristol Myers Squibb (BMY)?
The 5-year average PE ratio for BMY stock is 20.56.
What is the highest PE ratio for BMY?
Over the last ten years, the quarterly PE ratio reached its highest level at 221.36 in the Jun 2018 quarter.
How does the current PE ratio for BMY compare to its historical average?
BMY's price to earnings ratio is currently 60% below its 10-year historical average.
How is BMY's PE ratio calculated (Bristol Myers Squibb PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 16, 2025), Bristol Myers Squibb's share price is $46.75. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $2.68. Therefore, Bristol Myers Squibb's price to earnings ratio for today is 17.44. PE RATIO(17.44) = STOCK PRICE($46.75) / TTM EPS($2.68)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.